IN2015DN00205A - - Google Patents

Info

Publication number
IN2015DN00205A
IN2015DN00205A IN205DEN2015A IN2015DN00205A IN 2015DN00205 A IN2015DN00205 A IN 2015DN00205A IN 205DEN2015 A IN205DEN2015 A IN 205DEN2015A IN 2015DN00205 A IN2015DN00205 A IN 2015DN00205A
Authority
IN
India
Prior art keywords
hif
relates
present
responsive reporter
constructs
Prior art date
Application number
Other languages
English (en)
Inventor
Norazizah Shafee
Eric J Stanbridge
Khatijah Yusoff
Sien Yei LIEW
Original Assignee
Universiti Putra Malaysia U P M
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universiti Putra Malaysia U P M filed Critical Universiti Putra Malaysia U P M
Publication of IN2015DN00205A publication Critical patent/IN2015DN00205A/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/66Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving luciferase
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5023Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on expression patterns
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475Assays involving growth factors
    • G01N2333/505Erythropoietin [EPO]
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value
    • G01N2500/04Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value
    • G01N2500/10Screening for compounds of potential therapeutic value involving cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/70Mechanisms involved in disease identification
    • G01N2800/7038Hypoxia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
IN205DEN2015 2012-08-02 2013-01-29 IN2015DN00205A (https=)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
MYPI2012003492A MY172311A (en) 2012-08-02 2012-08-02 Hypoxia inducible factor (hif) activity reporter cell line
PCT/MY2013/000013 WO2014021705A1 (en) 2012-08-02 2013-01-29 Hypoxia inducible factor (hif) activity reporter cell line

Publications (1)

Publication Number Publication Date
IN2015DN00205A true IN2015DN00205A (https=) 2015-06-12

Family

ID=48040394

Family Applications (1)

Application Number Title Priority Date Filing Date
IN205DEN2015 IN2015DN00205A (https=) 2012-08-02 2013-01-29

Country Status (7)

Country Link
US (1) US9995730B2 (https=)
EP (1) EP2880177B1 (https=)
JP (1) JP6309520B2 (https=)
CN (1) CN104662164A (https=)
IN (1) IN2015DN00205A (https=)
MY (1) MY172311A (https=)
WO (1) WO2014021705A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101849964B1 (ko) * 2016-07-26 2018-04-19 울산대학교 산학협력단 Il-7 발현 리포터 세포주 및 이를 이용한 면역결핍 질환 치료제 스크리닝 방법
AU2021240417A1 (en) * 2020-03-26 2022-10-20 AskBio Inc. Forskolin-inducible promoters and hypoxia-inducible promoters

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5834306A (en) * 1994-12-23 1998-11-10 Sri International Tissue specific hypoxia regulated therapeutic constructs
WO2005001136A1 (en) * 2003-06-04 2005-01-06 Irm Llc Methods and compositions for modulating erythropoietin expression

Also Published As

Publication number Publication date
MY172311A (en) 2019-11-21
US20150168376A1 (en) 2015-06-18
EP2880177B1 (en) 2017-07-19
JP6309520B2 (ja) 2018-04-11
CN104662164A (zh) 2015-05-27
WO2014021705A1 (en) 2014-02-06
JP2015524272A (ja) 2015-08-24
EP2880177A1 (en) 2015-06-10
US9995730B2 (en) 2018-06-12

Similar Documents

Publication Publication Date Title
MX337984B (es) Variantes de alfa amilasa y polinucleotidos que codifican la misma.
IN2014CN02469A (https=)
MX355356B (es) Variantes de alfa-amilasa y polinucleotidos que codifican las mismas.
IN2014CN00650A (https=)
IN2014CN00597A (https=)
MX354704B (es) Variantes de alfa-amilasa y polinucleotidos que codifican las mismas.
IN2014CN03468A (https=)
EP4428141A3 (en) Rna-guided targeting of genetic and epigenomic regulatory proteins to specific genomic loci
MX2012007709A (es) Variantes de alfa-amilasa con estabilidad mejorada.
IL240881A0 (en) Expression of the t cell balance gene, preparations, materials and methods for its use
MX2013007853A (es) Polipeptidos que tienen actividad de celobiohidrolasa y polinucleotidos que codifican los mismos.
MX337919B (es) Polipeptidos que tienen actividad de celobiohidrolasa y polinucleotidos que codifican los mismos.
MY203884A (en) Taurine supplemented cell culture medium and methods of use
MX351916B (es) Polipeptidos que tienen actividad de lisozima y polinucleotdos que los codifican.
IN2015KN00265A (https=)
MX2013001459A (es) Proceso para transfeccion de plantas.
EP2997130A4 (en) Feeder-free derivation of human-induced pluripotent stem cells with synthetic messenger rna
MX2021013104A (es) Variantes de lipasa y polinucleotidos que las codifican.
MX2013004892A (es) Polipeptidos que tienen actividad de fosfolipasa c y polinucleotidos que codifican los mismos.
NZ729980A (en) Genes involved in noscapine production
SG10201805087VA (en) Artificial match-type mirna for controlling gene expression and use therefor
MX2014001594A (es) Polipeptidos que tienen actividad de celulasa y polinucleotidos que los codifican.
EP3054765A4 (en) Interfering with hd-zip transcription factor repression of gene expression to produce plants with enhanced traits
WO2014195356A3 (en) Alpha-amylase variants and polynucleotides encoding same
MX349517B (es) Polipeptidos que tienen actividad de proteasa y polinucleotidos que codifican los mismos.